Details
Description
In this analysis, we characterized use of hydroxyurea among patients with sickle cell disease (SCD) in the Sentinel Distributed Database (SDD). This analysis contains two reports:
- Report 1: We described use of hydroxyurea among patients with SCD in the SDD. The study period includes data from January 1, 2000 to December 31, 2020. We distributed this request to seven Sentinel Data Partners on July 27, 2021.
- Report 2: We described patients with SCD who were and were not dispensed hydroxyurea, and estimated the number of hospitalizations and emergency department visits among those patients in the SDD. The study period includes data from January 1, 2000 to September 30, 2020. We distributed this request to seven Sentinel Data Partners on April 30, 2021.